Joel Tune
Mr. Joel Tune currently serves as Enteris BioPharma’s Executive Chairman of the Board of Directors and Chief Executive Officer. He joined the Company in July 2013, initially serving as the Executive Chairman of the Board of Directors. In January 2016, Mr. Tune assumed the role of Chief Executive Officer of Enteris BioPharma. Joel is a highly seasoned executive with an extensive knowledge of strategy, operations and business development.
Prior to joining Enteris BioPharma, Mr. Tune spent 28 years with Baxter HealthCare Corp. in roles of increasing responsibility within product development, sales and marketing, strategy, mergers and acquisitions and general management. His last role at Baxter was as Vice President and General Manager of the BioPharma Solutions Business, with global responsibility for the rapidly growing $800M franchise. Since leaving Baxter he has served as an independent consultant to a variety of private equity, venture capital and healthcare start-up firms, including serving on the Board of Directors for Unigene Laboratories and Epic Therapeutics.
Mr. Tune holds an MBA from Marquette University and a BS in Biomedical Engineering from University of Louisville.